What’s in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension-Reference-Cited by-同舟云学术

What’s in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension

Published:2017-08 Issue: Volume:240 Page:386-391
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Leary Peter J.,Kang Suhyun,Kolb Todd M.,Maron Bradley A.,Ralph David D.,Rao Youlan,Tedford Ryan J.,Zamanian Roham T.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry;D'Alonzo;Ann. Intern. Med.,1991

2. Survival in pulmonary hypertension in Spain: insights from the Spanish registry;Escribano-Subias;Eur. Respir. J.,2012

3. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension;Galiè;Eur. Heart J.,2009

4. Tadalafil therapy for pulmonary arterial hypertension;Galiè;Circulation,2009

5. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial;Simonneau;Am. J. Respir. Crit. Care Med.,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer;Journal of the American Heart Association;2023-04-18

2. Compression Stockings Improve Lower Legs Symptom in Patients with Pulmonary Artery Hypertension Treated by Pulmonary Vasodilators—A Pilot Study;Journal of Clinical Medicine;2023-03-24

3. Irbesartan ameliorates chronic mountain sickness in a rat model via the cholesterol metabolism: An iTRAQ -based proteomics analysis;Biomedicine & Pharmacotherapy;2021-09

4. Intravenous Delivery of Lung‐Targeted Nanofibers for Pulmonary Hypertension in Mice;Advanced Healthcare Materials;2021-06

5. Research on the improvement of oxidative stress in rats with high-altitude pulmonary hypertension through the participation of irbesartan in regulating intestinal flora;EUR REV MED PHARMACO;2021